학술논문

Trastuzumab deruxtecan (DS-8201a)in patients with advanced HER2-positive breast cancer previously treated with trastuzumab emtansine: a dose-expansion, phase 1 study
Document Type
Article
Source
In: The Lancet Oncology. (The Lancet Oncology, June 2019, 20(6):816-826)
Subject
Language
English
ISSN
14745488
14702045